PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Lisinopril - Heart failure
PAD Profile : Lisinopril - Heart failure
Traffic Light Status
Status 1 of 1.
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Eplerenone
- Ivabradine
- Sacubitril/valsartan
- Digoxin
- Spironolactone
- Co-amilozide (Amiloride hydrochloride/hydrochlorot
- Dapagliflozin
- Empagliflozin
- Metolazone
- Ramipril
- Captopril
- Enalapril maleate
- Perindopril erbumine
- Bisoprolol fumarate
- Carvedilol
- Nebivolol
- Candesartan cilexetil
- Losartan potassium
- Valsartan
- Prazosin hydrochloride
- Hydralazine hydrochloride
- Acetazolamide
- Levosimendan
- Enoximone
- Milrinone lactate
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
04 September 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
Associated BNF Codes
02. Cardiovascular System
02.05.05. Renin-angiotensin system drugs